1 The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19.

2 The Italian Society of Rheumatology clinical practice guidelines for the management of polymyalgia rheumatica.

3 Community-based participatory action research on rheumatic heart disease in an Australian Aboriginal homeland: Evaluation of the ‘On track watch’ project

4 Prolonged PR Interval and Erythema Marginatum in a Child with Acute Rheumatic Fever

5 Italian recommendations for influenza and pneumococcal vaccination in adult patients with autoimmune rheumatic diseases.

6 Maternal and fetal outcomes in pregnant women undergoing balloon mitral valvotomy for rheumatic mitral stenosis

7 Comparison of the big five personality traits in fibromyalgia and other rheumatic diseases

8 Clinic factors associated with better delivery of secondary prophylaxis in acute rheumatic fever management.

9 Echocardiographic screening for rheumatic heart disease in Turkish school children.

10 A follow-up study of occupational styrene exposure and risk of autoimmune rheumatic diseases.

11 Feasibility and face validity of outcome measures for use in future studies of Polymyalgia Rheumatica (PMR): An OMERACT Study.

12 Fighting flu: the importance of vaccines in rheumatic disease

13 Do patients with rheumatic diseases living in rural settings have poorer outcomes? Results from a systematic review of the literature.

14 COVID-19, immune system response, hyperinflammation and repurposing anti-rheumatic drugs.

15 Being a rheumatologist and a patient with a rheumatic disease today: A perspective at the time of COVID-19.

16 Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: a population-based study in the first two months of COVID-19 outbreak in Italy.

17 Vitamin D deficiency in chronic inflammatory rheumatic diseases: results of the cardiovascular in rheumatology [CARMA] study.

18 Early, Incomplete, or Preclinical Autoimmune Systemic Rheumatic Diseases and Pregnancy Outcome

19 Effects of upadacitinib on patient-reported outcomes: results from SELECT-BEYOND, a phase 3 randomized trial in patients with rheumatoid arthritis and inadequate responses to biologic disease-modifying antirheumatic drugs

20 Effects of upadacitinib on patient-reported outcomes: results from SELECT-BEYOND, a phase 3 randomized trial in patients with rheumatoid arthritis and inadequate responses to biologic disease-modifying antirheumatic drugs

21 [Prolactin, a link between the neuroendocrine and immune systems. Role in the pathogenesis of rheumatic diseases]

22 use of disease-modifying anti-rheumatic drugs in the therapy of osteoarthritis

23 the expansion of myeloid-derived suppressor cells is associated with joint inflammation in rheumatic patients with arthritis

24 systemic light chain amyloidosis mimicking rheumatic disorders

25 gold finger: metal jewellery as a disease modifying antirheumatic therapy!

26 vacinação contra febre amarela em pacientes com diagnósticos de doenças reumáticas, em uso de imunossupressores vaccination against yellow fever among patients on immunosuppressors with diagnoses of rheumatic diseases

27 maternal and fetal outcomes in pregnant women undergoing balloon mitral valvotomy for rheumatic mitral stenosis

28 cardiovascular imaging techniques in systemic rheumatic diseases

29 correction to: pain, functional disability, and their association in juvenile fibromyalgia compared to other pediatric rheumatic diseases

30 relapse of polymyalgia rheumatica following adjuvanted influenza vaccine: a case-based review

31 auranofin, an anti-rheumatic gold compound, modulates apoptosis by elevating the intracellular calcium concentration ([ca2+]i) in mcf-7 breast cancer cells

32 Flourensia fiebrigii S.F. blake: A medicinal plant from the Argentinean highlands with potential use as anti-rheumatic and anti-inflammatory

33 assessment of rv function following percutaneous transvenous mitral commissurotomy (ptmc) for rheumatic mitral stenosis

34 high sensitive c-reactive protein and interleukin 6 in atrial fibrillation with rheumatic mitral stenosis from indian cohort

35 balloon valvotomy for rheumatic valvar stenosis in a patient with complex congenital heart disease

36 clinical characteristics of nocardia infection in patients with rheumatic diseases

37 correlation of serum vitamin d levels with severity of rheumatic mitral valve calcification

38 the impact of disease and antirheumatic therapy factors on growth retardation in children suffering from juvenile rheumatoid arthritis

39 differential x-ray diagnosis of changes in the joints of the hands and the distal foot in rheumatic diseases

40 actualización en polimialgia reumática polymyalgia rheumatica revisited

41 decreased levels of serum platelet-activating factor acetylhydrolase in patients with rheumatic diseases

42 a cross-sectional study to look at the determinants of poor adherence to secondary penicillin prophylaxis for rheumatic heart disease at a tertiary care center in south india

43 Outcomes of severe systemic rheumatic disease patients requiring extracorporeal membrane oxygenation

44 Group G Streptococcus Induces an Autoimmune Carditis Mediated by Interleukin 17A and Interferon γ in the Lewis Rat Model of Rheumatic Heart Disease

45 Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy

46 Rheumatic fever and rheumatic heart disease in developing countries

47 Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis

48 Rheumatic Fever, Rheumatic Heart Disease, and the Streptococcal Connection: The Role of Streptococcal Antigens Cross-Reactive with Heart Tissue

49 Pathogenic or Therapeutic Extracellular Vesicles in Rheumatic Diseases: Role of Mesenchymal Stem Cell-Derived Vesicles

50 Computational analysis to investigate the anti-rheumatic potential of plant-based small molecule inhibitor targeting tumor necrosis factor .

51 EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update.

Keyword Connections

Journals

Research Groups

Bibliographies